Wegovy dosing depends on the prescribed formulation
Published by GLP-1 Coverage Guide · Updated · No clinician review is credited for this page.
Short answer: Wegovy injection and tablets have separate dosing schedules. The label starts injection at 0.25 mg weekly for four weeks and tablets at 1.5 mg daily for 30 days. These are label summaries, not personalized dosing instructions.
Sources for the coverage rules are listed below. An update date marks a revision; it does not imply a sitewide medical review.
Use the form-specific label
The label’s usual recommended injection maintenance dose is 2.4 mg weekly; other maintenance choices depend on indication and the full prescribing information. The tablet maintenance dose for adult weight reduction or cardiovascular-risk reduction is 25 mg daily. Do not convert milligram amounts between forms yourself.
Ask the prescriber for the full escalation schedule, what to do about missed doses, and which symptoms require prompt medical advice. Do not change or restart medication based on this coverage guide.
Coverage uses fills, not a promised titration calendar
CMS covers authorized 28-day or 30-day Bridge fills at $50 each. The correct supply and prescription strength depend on the chosen formulation and clinical instructions. Count actual fills when comparing costs; do not assume every calendar month corresponds to an identical fill.
Take the Medicare eligibility check →
Common questions
Does the $50 copay guarantee treatment is appropriate?
No. Eligibility, authorization, pharmacy supply and clinical suitability are separate checks.
Can I change the dose or formulation myself?
Discuss changes with your prescriber and pharmacist. Follow the prescribed instructions and current form-specific labeling.
Related
Sources: CMS covered formulations and process · CMS prior authorization form · Current Wegovy injection and tablet prescribing information